|
TRA2A expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.28760005067153E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22780000003198E-06 |
| Normal-vs-Stage2 |
8.30850000022032E-07 |
| Normal-vs-Stage3 |
5.83459947023357E-11 |
| Normal-vs-Stage4 |
4.07960000003982E-06 |
| Stage1-vs-Stage2 |
1.188210E-01 |
| Stage1-vs-Stage3 |
1.439100E-03 |
| Stage1-vs-Stage4 |
8.384200E-02 |
| Stage2-vs-Stage3 |
4.492400E-01 |
| Stage2-vs-Stage4 |
7.100400E-01 |
| Stage3-vs-Stage4 |
8.450800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.42710000378332E-08 |
| Normal-vs-AfricanAmerican |
1.78449999999053E-06 |
| Normal-vs-Asian |
4.936700E-03 |
| Caucasian-vs-AfricanAmerican |
1.967580E-01 |
| Caucasian-vs-Asian |
1.077840E-01 |
| AfricanAmerican-vs-Asian |
2.864400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55059999999274E-05 |
| Normal-vs-Female |
7.59890039780942E-10 |
| Male-vs-Female |
3.028400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.123300E-03 |
| Classical-VS-Follicular |
6.222400E-01 |
| Classical-VS-Other |
2.576000E-01 |
| Classical-VS-Normal |
1.25569999953612E-07 |
| Tall-VS-Follicular |
1.162330E-02 |
| Tall-VS-Other |
9.641700E-02 |
| Tall-VS-Normal |
6.27149998599918E-10 |
| Follicular-VS-Other |
3.133000E-01 |
| Follicular-VS-Normal |
6.02379999999902E-05 |
| Other-VS-Normal |
3.727200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.67890004307981E-09 |
| Normal-vs-N1 |
5.179400E-03 |
| N0-vs-N1 |
2.134200E-01 |
|
|
